TTK Healthcare Limited (TTKHLTCARE) AI Stock Analysis

• Market Cap: ₹12.28B
• Dividend Yield: 0.95%
• Average Volume (3M): 82.00
• Price to Earnings (P/E): 34.8
• Beta (1Y): 0.77
• Revenue Growth: 6.98%
• EPS Growth: -17.11%
• Country: IN
• Employees: 1,316
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - General
• EPS (TTM): 7.45
• Shares Outstanding: 14,130,333
• 10 Day Avg. Volume: 50
• 30 Day Avg. Volume: 82
• PEG Ratio: 0.68
• Price to Book (P/B): 1.57
• Price to Sales (P/S): 1.91
• P/FCF Ratio: -99.33
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: ₹869.00 ▼(-15.55% Downside)
• Action: Downgraded Date: 03/21/26
• Date: Action: Downgraded 03/21/26

The score is primarily supported by strong financial performance (revenue growth and a stable, low-debt balance sheet), but it is meaningfully reduced by weak cash flow quality and a bearish technical trend. Valuation is only moderate due to a high P/E with a modest dividend yield.

Positive Factors

Balance Sheet Health

Low leverage and a strong equity ratio provide durable financial flexibility. A healthy balance sheet and high ROE support investment in brands, capex, or targeted M&A, and increase resilience to sector downturns and working-capital pressure over the next 2–6 months.

Negative Factors

Weak Cash Generation

Persistent negative operating and free cash flow weakens the link between reported earnings and liquidity. Over 2–6 months this constrains funding for working capital, capex, dividends or buybacks, may necessitate external financing, and raises earnings-quality concerns.

TTK Healthcare Limited Business Overview & Revenue Model

Company Description

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulati...

Read more

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulati...

How the Company Makes Money

TTK Healthcare makes money primarily by selling products across its healthcare and consumer segments. Key revenue streams include: (1) Branded pharmaceuticals/formulations: revenue earned from the sale of prescription and other pharmaceutical prod...

Read more

TTK Healthcare makes money primarily by selling products across its healthcare and consumer segments. Key revenue streams include: (1) Branded pharmaceuticals/formulations: revenue earned from the sale of prescription and other pharmaceutical prod...

TTK Healthcare Limited Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	8.25B	8.73B	7.48B	7.25B	5.99B	4.76B
Gross Profit	5.48B	5.04B	4.07B	3.77B	3.09B	1.38B
EBITDA	1.01B	1.06B	999.35M	796.81M	406.58M	373.52M
Net Income	662.66M	816.57M	628.42M	6.40B	415.88M	464.41M
Balance Sheet
Total Assets	12.96B	12.81B	12.01B	11.70B	5.59B	4.94B
Cash, Cash Equivalents and Short-Term Investments	6.01B	8.55B	8.45B	8.47B	2.73B	2.27B
Total Debt	285.86M	242.19M	228.11M	273.29M	222.13M	191.44M
Total Liabilities	2.10B	2.16B	2.00B	2.17B	2.29B	2.00B
Stockholders Equity	10.85B	10.65B	10.01B	9.53B	3.30B	2.95B
Cash Flow
Free Cash Flow	-254.40M	-168.16M	-153.27M	-377.75M	385.02M	946.88M
Operating Cash Flow	-225.48M	-39.76M	-49.43M	-260.76M	449.96M	964.21M
Investing Cash Flow	397.52M	201.03M	284.94M	329.59M	-305.47M	-772.39M
Financing Cash Flow	-135.11M	-180.81M	-219.11M	-124.26M	-51.77M	-171.56M

TTK Healthcare Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1029.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TTKHLTCARE, the sentiment is Neutral. The current price of 1029 is above the 20-day moving average (MA) of 817.85, above the 50-day MA of 886.07, and below the 200-day MA of 1089.37, indicating a neutral trend. The MACD of -16.14 indicates Negative momentum. The RSI at 55.70 is Neutral, neither overbought nor oversold. The STOCH value of 86.39 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:TTKHLTCARE.

TTK Healthcare Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WINDLAS	71 Outperform	₹16.96B	27.93	―	0.71%	19.34%	9.32%
SMSPHARMA	70 Outperform	₹38.91B	29.96	―	0.13%	11.91%	36.92%
VIMTALABS	67 Neutral	₹19.57B	38.21	―	0.16%	17.05%	56.84%
TTKHLTCARE	64 Neutral	₹12.28B	34.84	―	0.95%	6.98%	-17.11%
AMRUTANJAN	63 Neutral	₹15.50B	24.83	―	0.68%	7.36%	19.31%
BAJAJHCARE	53 Neutral	₹10.23B	20.91	―	0.24%	13.04%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%